我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
5
1 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中（未招募）
1
20.0%
已完成
2
40.0%
Temporarily Not Available
终止
暂无批准数据
- ProKidney focuses on its US-based Phase 3 trial of rilparencel for type 2 diabetes and chronic kidney disease, discontinuing a trial in Spain. - Amarna Therapeutics receives FDA guidance on its AM510 gene therapy for type 1 diabetes, aiming for tolerance induction. - Vertex's VX-880 continues to show potential in reducing or eliminating the need for insulin in type 1 diabetes patients. - PolarityTE screens first patient for SkinTE pivotal trial for diabetic foot ulcers, addressing a critical complication of diabetes.
